Ohio Study Shows Measles Immunity Gaps Persist Twenty Months After Major Postelimination Outbreak

MMR vaccination rates in Ohio remain far below herd immunity levels 20 months after the 2022 outbreak, with significant first-dose delays in Somali subgroups.

By: AXL Media

Published: Apr 24, 2026, 6:44 AM EDT

Source: Information for this report was sourced from EurekAlert!

Persistent Immunity Deficits in the Wake of Viral Resurgence

The conclusion of a major measles outbreak in central Ohio has not resulted in the expected surge of population-wide immunity, according to recent findings presented in Boston. Rosemary Martoma, MD, a fellow at Boston Children's Hospital and Harvard Medical School, stated that these outbreaks reveal, but do not necessarily resolve, the underlying gaps in vaccination coverage. The study indicates that the system remains fragile, as immunity levels in the monitored primary care network have stayed well below the necessary benchmarks to prevent sustained transmission of the highly contagious disease.

Quantitative Analysis of Vaccination Timing and Network Coverage

To assess the effectiveness of post-outbreak interventions, investigators analyzed the records of 133,476 children within a central Ohio medical network. According to the research data, the timely administration of the first MMR dose sat at just 53.6% when the outbreak began and showed no statistically significant improvement twenty months later. While the timely second dose saw a modest rise from 57.9% to 60.2%, the overall percentage of children receiving at least one valid dose only increased by 0.6 percentage points, reaching a final total of 77.9%.

Disparities in Immunization Rates Among Somali Heritage Populations

The research specifically tracked outcomes for children of Somali descent, a group identified in prior reports as being disproportionately affected by the virus. According to the binomial generalized linear models used in the study, Somali children had a timely first-dose vaccination rate approximately 20 percentage points lower than their peers across all monitored time points. Interestingly, the study found that differences in the second-dose and any-dose coverage between Somali and non-Somali children were small and not statistically significant by the end of the 20-month observation period.